Trademarkia Logo

United Kingdom

£
Registered

on 29 Apr 2021

Last Applicant/ Owned by

EmpowerPharm Inc.

5575 North Service Road, Suite 603, Burlington, Ontario

, , L7L 6M1

Serial Number

UK00003634826 filed on 29th Apr 2021

Registration Number

UK00003634826 registered on
3rd Jun 2022

Correspondent Information

J A Kemp LLP

80 Turnmill Street

London,

EC1M 5QU

EmpowerPharm

pharmaceutical preparations containing synthetic cannabidiol (cbd) for the treatment of various diseases, conditions and disorders; pharmaceutical pre Read More

Classification Information


Class [5]
Pharmaceutical Products


Pharmaceutical preparations containing synthetic cannabidiol (CBD) for the treatment of various diseases, conditions and disorders; Pharmaceutical preparations containing synthetic cannabidiol (CBD) for the treatment of anxiety, stress, pain and insomnia; Pharmaceutical preparations containing synthetic cannabidiol (CBD) for the treatment of anxiety; Natural health products, namely, glucosamine, turmeric supplements, dietary supplements to aid digestion, melatonin, sleep support supplements, fish oils, probiotics in tablet, capsule, gummy vitamin and liquid form; vitamin supplements; mineral supplements; vitamin and mineral food supplements; vitamin and mineral dietary supplements; vitamin preparations; mineral preparations; multivitamins; prenatal vitamins; calcium supplements; nutritional supplements for general health and well-being, namely magnesium in tablets, capsules, gummies, and liquids; dietary supplements for promoting weight loss; over the counter medications for treating aches, pains, headaches, arthritis pain, sprains, and for treatment of minor joint injuries and muscle soreness; nonsteroidal anti-inflammatory drugs (NSAIDs); ibuprofen; naproxen sodium; acetaminophen; cold, sore throat and cough medications; guaifenesin; liquid cough medicines with dextromethorphan; decongestant nasal sprays; pseudoephedrine; phenylephrine; allergy medications; antihistamine pills and liquids; diphenhydramine; chlorpheniramine; brompheniramine; loratadine; fexofenadine; cetirizine; stomach upset medications, namely probiotic preparations for medical purposes to help maintain a natural balance of flora in the digestive system; antidiarrhea medicines; loperamide; bismuth; nausea treatment preparations; pharmaceutical preparations for the treatment of vomiting and motion sickness; dimenhydrinate; cannabidiol (CBD) oil for medical purposes; cannabidiol (CBD) for medical purposes; cannabidiol (CBD) for medical purposes in the form of suppositories, sublingual doses that dissolve in the mouth, creams, ointments, and doses for absorption in the mucous membranes; tablets, capsules, gummies, suppositories, skin patches, sublingual doses, extended release tablets and liquids for therapeutic purposes containing cannabidiol (CBD); herbal supplements containing cannabidiol (CBD); Liquid nutritional supplement containing cannabidiol (CBD) for treating, reducing or improving symptoms of various conditions, namely, pain, anxiety, depression, cancer, acne, skin conditions, neuroprotection, cardiovascular health, arthritis, inflammation, autoimmune conditions, epileptic seizures, nausea, appetite, inflammatory bowel disease, and insomnia; tetrahydrocannabinol (THC) for medical purposes; tetrahydrocannabinol (THC) for medical purposes in sublingual doses and doses for absorption in the mucous membranes; tablets, capsules, gummies, suppositories, skin patches, sublingual doses, extended release tablets and liquid for therapeutic purposes containing tetrahydrocannabinol (THC) and containing a combination of tetrahydrocannabinol (THC) together with cannabidiol (CBD).

Mark Details


Serial Number

UK00003634826

Mark Type

Word

Kind of mark

Individual